Medical research funding cuts have emerged as a pressing concern that threatens the integrity and efficacy of clinical trials nationwide.The recent freeze on federal grants, amounting to over $2 billion, has placed substantial strain on research institutions, disrupting vital oversight mechanisms essential for ensuring patient safety in research.